Fund shareholders of Summit Therapeutics Inc
ISIN US86627T1088 · United States
- Fund shareholders
- 167
- Of which ETFs
- 46 121 other funds
- Value held
- 727.4M $ 1.1M € · 8.1M SEK
- Share of capital
- 4.9 % of 797.7M shares on Jul 17, 2026
167 funds hold this company: 166 declare it in a regulatory filing, and this table serves those page by page; 1 more is read from the report its fund publishes, and is not in it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 5,948,323 | 112.8M $ | 1.04 % | 0.75 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 4,866,448 | 92.3M $ | 1.24 % | 0.61 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,755,154 | 71.2M $ | 0.00 % | 0.47 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,680,105 | 50.8M $ | 0.03 % | 0.34 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,382,737 | 39.5M $ | 0.05 % | 0.30 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,718,526 | 32.6M $ | 0.04 % | 0.22 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1,707,539 | 32.4M $ | 0.05 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,089,169 | 18.1M $ | 0.34 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1,000,000 | 16.6M $ | 0.27 % | 0.13 % | as of Feb 28, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 924,148 | 15.3M $ | 0.23 % | 0.12 % | as of Feb 27, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 799,477 | 15.2M $ | 0.19 % | 0.10 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 782,939 | 14.8M $ | 0.08 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 777,508 | 12.9M $ | 0.03 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 719,947 | 11.9M $ | 0.05 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 626,783 | 10.4M $ | 0.05 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 489,110 | 9.3M $ | 0.01 % | 0.06 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 480,979 | 9.1M $ | 0.01 % | 0.06 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 449,261 | 8.5M $ | 0.02 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 446,795 | 7.4M $ | 0.04 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 437,979 | 7.3M $ | 0.03 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 432,667 | 9.3M $ | 0.02 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 404,312 | 6.7M $ | 0.05 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 400,000 | 8.6M $ | 0.30 % | 0.05 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 362,900 | 6.9M $ | 1.04 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 331,782 | 5.5M $ | 0.61 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 278,847 | 6M $ | 1.15 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 276,077 | 4.6M $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 220,646 | 3.7M $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 210,850 | 4M $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 192,861 | 3.2M $ | 0.01 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 187,656 | 3.1M $ | 0.03 % | 0.02 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 180,000 | 3.4M $ | 0.34 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 169,304 | 2.8M $ | 0.19 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 166,159 | 3.6M $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 160,550 | 3M $ | 0.07 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 153,060 | 2.5M $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 142,674 | 2.7M $ | 0.08 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 131,177 | 2.5M $ | 1.09 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 129,855 | 2.5M $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 110,918 | 1.8M $ | 1.15 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 102,422 | 2.2M $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 97,340 | 1.8M $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 91,577 | 1.5M $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 90,599 | 1.7M $ | 1.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 90,467 | 1.9M $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 89,491 | 1.9M $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 86,301 | 1.9M $ | 1.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 82,925 | 1.6M $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 79,596 | 1.7M $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Large-Cap Value ETF SCHWAB STRATEGIC TRUST | 77,990 | 1.3M $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 69,598 | 1.3M $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 67,001 | 1.3M $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 66,729 | 1.4M $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 61,900 | 1.2M $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 59,534 | 1.3M $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Morningstar Mid-Cap Growth ETF iShares Trust | 57,051 | 1.2M $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 54,464 | 1M $ | 0.29 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 54,366 | 1.2M $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 53,512 | 1M $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 50,934 | 1.1M $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 49,213 | 933.1K $ | 0.69 % | 0.01 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 49,200 | 932.8K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 46,947 | 890.1K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Mid Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 45,768 | 982.2K $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 44,600 | 8.1M SEK | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2500 ETF iShares Trust | 43,400 | 822.9K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 42,174 | 699.7K $ | 0.92 % | 0.01 % | as of Feb 28, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 41,200 | 781.2K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 40,300 | 764.1K $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 1000 Equal Weight ETF Invesco Exchange-Traded Fund Trust II | 36,175 | 600.1K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 34,375 | 570.3K $ | 0.62 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 31,522 | 597.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Inspire 500 ETF Northern Lights Fund Trust IV | 31,371 | 520.4K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD ESG U.S. STOCK ETF VANGUARD WORLD FUND | 26,798 | 444.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 26,625 | 504.8K $ | 1.21 % | 0.00 % | as of Mar 31, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 24,874 | 471.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Systematic Growth Fund VALIC Co I | 24,402 | 404.8K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| BNY Mellon US Mid Cap Core Equity ETF BNY Mellon ETF Trust | 23,464 | 503.5K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 23,269 | 499.4K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap Index Fund SCHWAB CAPITAL TRUST | 22,556 | 484.1K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 22,288 | 422.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 21,703 | 411.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 20,966 | 449.9K $ | 0.74 % | 0.00 % | as of Apr 30, 2026 ↗ |
| NYLI Candriam U.S. Mid Cap Equity ETF New York Life Investments ETF Trust | 20,619 | 442.5K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Systematic Core Fund VALIC Co I | 20,458 | 339.4K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap Index Fund BlackRock Funds | 20,400 | 437.8K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED BALANCED FUND VANGUARD TAX-MANAGED FUNDS | 19,524 | 370.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 19,121 | 410.3K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 18,254 | 302.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Large-Cap Growth Index Fund SCHWAB CAPITAL TRUST | 17,629 | 378.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 17,600 | 292K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 15,708 | 337.1K $ | 0.90 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Blended Mid Cap Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 15,200 | 288.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GuideMark Large Cap Core Fund GPS Funds I | 13,367 | 253.4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Mid-Cap ETF iShares Trust | 12,305 | 264.1K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 11,718 | 222.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab 1000 Index ETF SCHWAB STRATEGIC TRUST | 11,314 | 187.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Large Cap Growth Index Portfolio EQ Advisors Trust | 10,440 | 197.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon U.S. Stock Market Index Fund JNL Series Trust | 10,252 | 194.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 10,098 | 191.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.36 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.24 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 1.21 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 1.15 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.15 % | as of Feb 28, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 1.09 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 1.08 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 1.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1.04 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 1.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 163 | -10 | 39,424,224 | -5.2 % |
| 2026Q1 | 173 | 0 | 41,579,277 | +21.2 % |
| 2025Q4 | 173 | -19 | 34,307,598 | +12.5 % |
| 2025Q3 | 192 | -26 | 30,502,278 | -9.7 % |
| 2025Q2 | 218 | +37 | 33,781,435 | +7.1 % |
| 2025Q1 | 181 | +15 | 31,541,381 | +10.8 % |
| 2024Q4 | 166 | +38 | 28,462,542 | -6.2 % |
| 2024Q3 | 128 | +8 | 30,351,670 | -8.2 % |
| 2024Q2 | 120 | +24 | 33,056,019 | +78.1 % |
| 2024Q1 | 96 | +7 | 18,555,239 | +15.8 % |
| 2023Q4 | 89 | 16,029,010 |
Institutional managers
216 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 36,391,063 | 690M $ | as of Mar 31, 2026 |
| FMR LLC | 10,853,199 | 205.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 9,653,758 | 183M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8,277,859 | 156.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,028,160 | 133.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,680,315 | 69.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,315,854 | 62.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,242,229 | 42.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,650,591 | 31.3M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,323,179 | 24M $ | as of Mar 31, 2026 |
| APEIRON CAPITAL Ltd | 1,309,141 | 24.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 981,185 | 18.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 960,867 | 18.2M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 956,894 | 18.1M $ | as of Mar 31, 2026 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 892,873 | 16.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 784,186 | 14.9M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 710,000 | 13.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 665,364 | 12.6M $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 613,877 | 11.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 603,933 | 11.5M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 598,692 | 11.4M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 592,810 | 11.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 581,600 | 11M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 548,335 | 10.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 540,662 | 10.3M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Summit Therapeutics Inc". https://titelia.com/en/stocks/summit-therapeutics-inc-US86627T1088